← Open Payments lookup

NPI 1710390539: Open Payments

NPI 1710390539. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$121 in 3 payments from 3 companies in 2025. Trend: 2023 $225 · 2024 $79 · 2025 $121

Food & beverage: $121
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$87
Vanda Pharmaceuticals Inc.1$20
Takeda Pharmaceuticals U.S.A., Inc.1$14

Products named: CAPLYTA, HETLIOZ, TRINTELLIX.